Product information and disease descriptionProduct descriptionProduct information
Drug/Drug, drug/disease interactions
4 evidence topics · 3 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionProduct descriptionProduct information
4 evidence topics · 3 sources